Picture EBD Group BIO-Europe 2026 Köln Cologne to 31 Jul 650x100px

Product › Details

clinical NMR-based test

	Next higher product group	clinical test (diagnostic test for human use)

Record changed: 2023-07-10

Picture Berlin Partner bio:cap Investival Life Science AI 650x200px

More documents for clinical test (diagnostic test for human use)

[1] Agilent Technologies Inc.. (2/11/26). "Press Release: Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)". Santa Clara, CA....
[2] Roche. (12/11/25). "Press Release: Roche Expands Automated Mass Spectrometry Menu with Antibiotics Drug Monitoring CE Mark Approval Offering Industry’s Broadest in vitro Diagnostic Menu". Basel....
[3] Abbott. (11/20/25). "Press Release: Abbott to Acquire Exact Sciences, a Leader in Large and Fast-growing Cancer Screening and Precision Oncology Diagnostics Segments". Abbott Park, IL & Madison, WI....
[4] Bruker Corporation. (4/16/25). "Press Release: Bruker Announces Majority Acquisition of Recipe, a Leading Provider of Mass Spectrometry-based Diagnostic Assay Kits for Therapeutic Drug Monitoring". Munich....
[5] Tecan Group Ltd.. (4/3/25). "Press Release: Tecan Expands Portfolio for Specialty Diagnostics with an Asset Purchase Relating to Certain ELISA kits". Männedorf....
[6] Roche. (12/18/24). "Press Release: Roche Transforms Mass Spectrometry Diagnostics with Launch of cobas Mass Spec Solution". Basel....
[7] Agilent Technologies Inc.. (12/10/24). "Press Release: Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR Certification". Santa Clara, CA....
[8] Mainz Biomed N.V.. (11/12/24). "Press Release: Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets". Berkeley, CA & Mainz....
[9] Noscendo GmbH. (4/22/24). "Press Release: Labor Dr. Wisplinghoff Partners with Noscendo – NGS-based Pathogen Diagnostics now an Established Part of Their Service Portfolio"....
[10] bioMérieux S.A.. (10/19/23). "Press Release: bioMérieux Makes Strategic Investment in Oxford Nanopore". Oxford & Marcy-l’Etoile....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com